Key result
PDE3B and EPAC1 form a signalosome recruiting PI3Kγ for cAMP-dependent regulation of arterial endothelial cells.
Why the study?
The mechanisms by which specific PDE3 variants, such as PDE3B, individually regulate PKA and EPAC activities in cardiovascular cells are poorly understood.
Identification of a PDE3B-based signalosome that integrates cAMP and PI3Kγ signals to regulate endothelial cell functions important in angiogenesis.
PDE3B-EPAC1-PI3Kγ complex may regulate endothelial angiogenesis functions; leaves open whether disrupting this signalosome alters cardiovascular outcomes.
Enzymes of the phosphodiesterase 3 (PDE3) and PDE4 families each regulate the activities of both protein kinases A (PKAs) and exchange proteins activated by cAMP (EPACs) in cells of the cardiovascular system. At present, the mechanisms that allow selected PDEs to individually regulate the activities of these two effectors are ill understood. The objective of this study was to determine how a specific PDE3 variant, namely PDE3B, interacts with and regulates EPAC1-based signaling in human arterial endothelial cells (HAECs). Using several biochemical approaches, we show that PDE3B and EPAC1 bind directly through protein-protein interactions. By knocking down PDE3B expression or by antagonizing EPAC1 binding with PDE3B, we show that PDE3B regulates cAMP binding by its tethered EPAC1. Interestingly, we also show that PDE3B binds directly to p84, a PI3Kγ regulatory subunit, and that this interaction allows PI3Kγ recruitment to the PDE3B-EPAC1 complex. Of potential cardiovascular importance, we demonstrate that PDE3B-tethered EPAC1 regulates HAEC PI3Kγ activity and that this allows dynamic cAMP-dependent regulation of HAEC adhesion, spreading, and tubule formation. We identify and molecularly characterize a PDE3B-based "signalosome" that integrates cAMP- and PI3Kγ-encoded signals and show how this signal integration regulates HAEC functions of importance in angiogenesis.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2011) studied this question. PDE3B knockdown or EPAC1 binding antagonism was evaluated on PDE3B-EPAC1 interaction and regulation of HAEC PI3Kγ activity, adhesion, spreading, and tubule formation. PDE3B and EPAC1 bind directly to form a signalosome that recruits PI3Kγ, allowing dynamic cAMP-dependent regulation of human arterial endothelial cell adhesion, spreading, and tubule formation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Biological Chemistry